Several studies have reported that S100A8/A9 has potential as a predictive biomarker in several inflammation-associated diseases such as rheumatism, inflammatory bowel disease, obesity, and atherosclerosis, among others (76, 77). The gene discussed is S100A8; the disease is rheumatic disorder.